{"query_echo":{"q":"","filters":{"analysis_type":["product audit"]},"warnings":[{"code":"facet_value_not_in_vocabulary","message":"Value 'product audit' for facet 'analysis_type' is not in the controlled vocabulary."}]},"total":{"value":2,"relation":"eq"},"page":1,"page_size":20,"self":"https://climateinsightsdirectory.org/api/v1/search?analysis_type=product+audit","stability":"beta","ai_marking":{"digital_source_type":{"uri":"http://cv.iptc.org/newscodes/digitalsourcetype/trainedAlgorithmicMedia","name":"Created using Generative AI"},"notice":"Summary and key insights are generated using artificial intelligence."},"results":[{"id":"chanmar-000053","url":"https://climateinsightsdirectory.org/document/chanmar-000053","title":"打破奶粉商科學神話","publisher":{"name":"Changing Markets Foundation","organization":"changing-markets-foundation"},"document_type":"report","language":"zh","date_published":"2018-02","source_url":"https://changingmarkets.org/wp-content/uploads/2023/10/Changing_Markets_Busting_the_Myth_Chinese.pdf","generator":"Climate Insights Directory","generated_fields":["summary","key_insights","climate_tags","geography_discussed","analysis_type"],"summary":{"text":"The report argues that Nestlé prioritizes profit and growth over nutritional science in its infant milk business. Through an analysis of 79 products in 40 countries, the authors found that Nestlé's marketing claims often contradict its own nutritional advice and the scientific evidence provided by bodies like the European Food Safety Authority (EFSA). Key discrepancies include the use of sucrose and flavorings in markets where the company advises against them, and the use of 'probiotic' claims in regions where such claims lack scientific authorization. The report concludes that 'premium' product differentiation is driven by consumer preferences and market trends rather than health outcomes.","ai_generated":true,"unit":"chanmar-000053#summary","date_modified":"2026-10-23"},"key_insights":[{"text":"Claims that certain products are 'closest to breast milk' are identified as marketing tactics rather than scientific facts, as the ingredients of products making this claim vary significantly across different countries.","ai_generated":true,"unit":"chanmar-000053#insight-1","date_modified":"2026-10-23"},{"text":"The 'Hungry Baby' formula sold by Nestlé in the UK is not recognized by European law, and the National Health Service (NHS) has rejected it due to a lack of evidence that it improves sleep quality or duration.","ai_generated":true,"unit":"chanmar-000053#insight-2","date_modified":"2026-10-23"}],"climate_tags":["public health"],"geography_discussed":["Hong Kong","South Africa","United Kingdom","United States","Switzerland","Spain","Poland"],"frame_perspective":[],"analysis_type":["product audit","comparative analysis","policy review"]},{"id":"chanmar-000245","url":"https://climateinsightsdirectory.org/document/chanmar-000245","title":"Milking it","publisher":{"name":"Changing Markets Foundation","organization":"changing-markets-foundation"},"document_type":"report","language":"en","date_published":"2017-10","source_url":"https://changingmarkets.org/wp-content/uploads/2023/10/Milking-it-Final-report-CM.pdf","generator":"Climate Insights Directory","generated_fields":["summary","key_insights","geography_discussed","analysis_type"],"summary":{"text":"The report examines the practices of Nestlé, Danone, Mead Johnson Nutrition, and Abbott, concluding that the proliferation of 'premium' and 'specialised' infant formulas is a strategy to increase market share and profit margins, particularly in Asia, often at the expense of breastfeeding promotion and consumer affordability.","ai_generated":true,"unit":"chanmar-000245#summary","date_modified":"2026-10-23"},"key_insights":[{"text":"The four largest infant formula manufacturers—Nestlé, Danone, Mead Johnson Nutrition, and Abbott—utilize product differentiation based on market research and consumer preferences rather than scientific or health considerations to increase profits.","ai_generated":true,"unit":"chanmar-000245#insight-1","date_modified":"2026-10-23"},{"text":"There is a significant disparity in the pricing of infant formula both within and between countries, with 'premium' products costing substantially more in Asian markets. In Indonesia, the most expensive first infant formula (Enfamil A+) is 4.5 times the price of the economy brand (SGM Ananda Presinutri 1).","ai_generated":true,"unit":"chanmar-000245#insight-2","date_modified":"2026-10-23"},{"text":"The same brand of formula is often priced differently across countries; for example, Danone's Aptamil Profutura 1 costs approximately 17 USD in the UK, 24 USD in Germany, and 55 USD in China.","ai_generated":true,"unit":"chanmar-000245#insight-3","date_modified":"2026-10-23"},{"text":"The cost of feeding an infant can represent a disproportionate share of average monthly salaries in growth markets. In China, super-premium formula can cost nearly 40% of an average monthly salary, and in Indonesia, it can reach nearly three-quarters of monthly income.","ai_generated":true,"unit":"chanmar-000245#insight-4","date_modified":"2026-10-23"},{"text":"BMS manufacturers frequently breach the WHO International Code of Marketing of Breastmilk Substitutes. According to the Access to Nutrition Index 2016, Nestlé was the most compliant with a score of 36%, while Abbott and Mead Johnson Nutrition scored under 10%.","ai_generated":true,"unit":"chanmar-000245#insight-5","date_modified":"2026-10-23"},{"text":"The nutritional quality of infant milks is largely dependent on industry self-regulation, with public authorities focusing more on contamination than on routine nutritional composition testing.","ai_generated":true,"unit":"chanmar-000245#insight-6","date_modified":"2026-10-23"},{"text":"Manufacturers are increasing the 'medicalisation' of infant formula by selling over-the-counter products that claim to treat general conditions like colic or constipation, despite limited evidence of efficacy.","ai_generated":true,"unit":"chanmar-000245#insight-7","date_modified":"2026-10-23"}],"climate_tags":[],"geography_discussed":["United States","United Kingdom","Germany","France","Poland","Bulgaria","Spain","Netherlands","Australia","New Zealand","South Africa","Singapore","Ireland"],"frame_perspective":[],"analysis_type":["market analysis","policy review","product audit"]}]}